Mike Stenberg, LGM Pharma, outlines how GLP-1s, AI, and 505(b)(2) delivery shifts are driving pharmaceutical innovation.

Objectives The use of economic evidence to prioritise vaccines and delivery strategies to optimally use in immunisation systems is becoming a global priority, especially in low- and middle-income ...

Technology alone is no longer enough. Organizations face an unprecedented proliferation of tools, platforms and systems, each ...

While police are coy about the exact strategies used to identify killers, the judge in the Desjardins case said, “scientific ...

Lockheed Martin is the prime F-35 contractor with principal partners Northrop Grumman and BAE Systems. The aircraft has three ...

Data Factor, New Quality Productive Forces, Industry-University-Research Cooperation, Industrial Structure Optimization Share ...

Research on the Influencing Factors and Configuration Paths of High-Quality Development of “Specialization, Refinement, ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Eric's career includes extensive work in both public and corporate accounting with ...

TCPalm journalists spent 2025 investigating issues, nonprofits, politicians, community concerns and the effects of new laws ...

Dark Reading Confidential Episode 13: Developers are exposing their organizations' most sensitive information; our guests ...

Smallholders produce significant quantities of Vietnam’s coffee, Indonesia’s palm oil, and Thailand’s rubber exported into ...